Angiogenic gene therapy does not cause retinal pathology.
- Published in:
- Journal of Gene Medicine, 2014, v. 16, n. 9/10, p. 309, doi. 10.1002/jgm.2806
- By:
- Publication type:
- Article
Works matching IS 1099498X AND DT 2014 AND VI 16 AND IP 9/10
Results: 7
1
2
Increased tumor distribution and expression of histidine-rich plasmid polyplexes.
- Published in:
- Journal of Gene Medicine, 2014, v. 16, n. 9/10, p. 317, doi. 10.1002/jgm.2807
- By:
- Publication type:
- Article
3
Conference Calendar.
- Published in:
- 2014
- Publication type:
- Other
4
Issue Information.
- Published in:
- 2014
- Publication type:
- Other
5
Targeted elimination of activated hepatic stellate cells by an anti-epidermal growth factor-receptor single chain fragment variable antibody-tumor necrosis factor-related apoptosis-inducing ligand (scFv425-sTRAIL).
- Published in:
- Journal of Gene Medicine, 2014, v. 16, n. 9/10, p. 281, doi. 10.1002/jgm.2776
- By:
- Publication type:
- Article
6
Long-term therapeutic and reporter gene expression in lentiviral vector treated cystic fibrosis mice.
- Published in:
- Journal of Gene Medicine, 2014, v. 16, n. 9/10, p. 291, doi. 10.1002/jgm.2778
- By:
- Publication type:
- Article
7
Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
- Published in:
- Journal of Gene Medicine, 2014, v. 16, n. 9/10, p. 300, doi. 10.1002/jgm.2779
- By:
- Publication type:
- Article